Bafna Pharma.

Bafna Pharmaceuticals Ltd Half Yearly Results

NSEBSE

₹76.92

(3.92%)

Apr 24, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Sept-2019	Mar-2019	Sept-2018
Gross Sales	18.41	22.57	20.79
Excise Duty	0	0	0
Net Sales	18.41	22.57	20.79
Other Operating Income	0	0	0
Other Income	0.89	1.61	0.06
Total Income	19.31	24.18	20.85
Total Expenditure	21.66	34.28	22.42
PBIDT	-2.35	-10.1	-1.58
Interest	0.17	0.68	1.45
PBDT	-2.52	-10.78	-3.03
Depreciation	1.74	1.72	1.75
Minority Interest Before NP	0	0	0
Tax	0	0	0
Deferred Tax	-1.54	1.06	0.01
Reported Profit After Tax	-2.72	-13.56	-4.79
Minority Interest After NP	0	0	0
Net Profit after Minority Interest	-2.72	-13.56	-4.79
Extra-ordinary Items	0	1.01	0
Adjusted Profit After Extra-ordinary item	-2.72	-14.57	-4.79
EPS (Unit Curr.)	-1.15	0	-3.01
Book Value (Unit Curr.)	0	0	0
Dividend (%)	0	0	0
Equity	23.66	23.66	23.66
Public Shareholding (Number)	0	0	0
Public Shareholding (%)	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0
Non Encumbered - No. of Shares	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0
Non Encumbered - % in Total Equity	0	0	0
PBIDTM(%)	-12.76	-44.74	-7.59
PBDTM(%)	-	-	-
PATM(%)	-14.77	-60.07	-23.03

No Record Found

Invest wise with Expert advice